PPLPHARMA.NS (NSE) is a cross-listing of PPLPHARMA.BO (BSE). Showing primary listing data.
PPLPHARMA.BO
Piramal Pharma Limited
1W: +1.4%
1M: -12.0%
3M: -27.9%
YTD: -13.7%
1Y: -37.8%
3Y: +33.7%
₹141.80 ($1.51)
+0.70 (+0.50%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹186.7B ($2.0B)
52W Range134.7-241
Volume195,913
Avg Volume182,229
Beta0.00
Dividend₹0.14
Analyst Ratings
No analyst coverage
Company Info
CEOPeter Daniel DeYoung
Employees6,719
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-10-19
507, Skyline Wealth Space
Mumbai 400 086
IN
Mumbai 400 086
IN
91 22 3802 3000
About Piramal Pharma Limited
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
Latest News
No recent news
Recent Insider Trades
No insider trades found